CELLSOURCE CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,522 JPY | +0.33% |
|
+3.75% | +19.00% |
| 2023 | Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2023. | CI |
| 2023 | MEDERI Inc. announced that it has received funding from CellSource Co., Ltd. | CI |
Chart calendar CellSource Co., Ltd.
b3d1d495f3629b4ce40ac4860.WE3HiNQ_YvZseTqeYrE8n6O3K1wwMwDa7npyULJYA0I.MAOWyr4MFL4UO0DEBd9a5dLVbxR5CkTph0MUKstvSHJhKIrRlXYkkSkOTQ~cacb04e192ffddd7dd48c2828e5c7706
Upcoming events on CellSource Co., Ltd.
Past events on CellSource Co., Ltd.
| 2024-03-10 | Q1 2024 Earnings Release |
| 2023-12-14 | Q4 2023 Earnings Release |
| 2023-09-12 | Q3 2023 Earnings Release |
| 2023-06-13 | Q2 2023 Earnings Release |
| 2023-03-13 | Q1 2023 Earnings Release |
| 2022-12-13 | FY 2022 Earnings Release |
| 2022-09-12 | Q3 2022 Earnings Release |
| 2022-06-12 | Interim 2022 Earnings Release |
| 2022-03-15 | Q1 2022 Earnings Release |
| 2021-12-12 | FY 2021 Earnings Release |
| 2021-09-09 | Q3 2021 Earnings Release |
| 2021-06-13 | Interim 2021 Earnings Release |
| 2021-03-14 | Q1 2021 Earnings Release |
| 2020-12-13 | FY 2020 Earnings Release |
| 2020-09-09 | Q3 2020 Earnings Release |
| 2020-06-14 | Interim 2020 Earnings Release |
| 2020-03-15 | Q1 2020 Earnings Release |
| 2019-12-11 | FY 2019 Earnings Release |
Past dividends on CellSource Co., Ltd.
| 2023-10-29 | Final Payment 5 JPY |
| 2023-10-29 | Bonus Payment 15 JPY |
Annual results
| Fiscal Period | October | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 1 611 | 1 855 1 870 -0.8% | 2 922 2 904 0.64% | 4 274 4 090 4.49% | 4 510 4 698 -3.99% | 4 895 |
|
EBITDA Million JPY | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 1 631 1 445 12.9% | 0,00 1 460 - | 957 |
|
EBIT Million JPY | Released Forecast Spread | 326 | 415 392 6% | 992 912 8.77% | 1 571 1 397 12.49% | 1 221 1 400 -12.79% | 841 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 303 | 412 395 4.3% | 1 006 0,00 - | 1 584 1 400 13.12% | 1 239 1 428 -13.24% | 853 |
|
Net income Million JPY | Released Forecast Spread | 199 | 274 251 9.38% | 651 575 13.22% | 1 018 881 15.53% | 923 978 -5.62% | 603 |
|
EPS JPY | Released Forecast Spread | 15,3 | 15,2 27,1 -44.03% | 35,2 31,0 13.57% | 54,5 47,2 15.66% | 48,9 50,2 -2.55% | 30,5 |
| Announcement Date | 12/12/19 | 14/12/20 | 13/12/21 | 14/12/22 | 15/12/23 | - |
Quarterly results
| Fiscal Period | October | 2020 S1 | 2021 S1 | 2022 Q1 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 | 2025 Q1 | 2025 Q2 | 2025 S1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 886 | 1 343 | 820 | 1 697 | 1 175 930 26.34% | 1 401 1 231 13.8% | 2 577 2 405 7.14% | 1 060 1 210 -12.44% | 1 111 1 163 -4.46% | 2 171 2 220 -2.22% | 1 236 | 1 174 1 217 -3.57% | 1 121 | 2 293 | 1 257 | 1 382 | 2 610 | 1 477 | 1 582 | 3 059 |
|
EBIT Million JPY | Released Forecast Spread | 187 | 422 | 244 | 490 | 448 | 633 462 37.02% | 1 081 909 18.93% | 351 440 -20.16% | 308 381 -19.15% | 659 730 -9.68% | 384 | 206 271 -24.04% | 196 | 401 | 260 | 212 | 580 | 326 | 385 | 710 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 187 | 435 | 244 | 495 | 451 290 55.52% | 638 454 40.45% | 1 089 905 20.29% | 340 440 -22.83% | 319 386 -17.29% | 659 720 -8.5% | 426 | 213 271 -21.51% | 289 | 498 | 209 | 171 | 326 | 385 | 710 | |
|
Net income Million JPY | Released Forecast Spread | 118 | 268 | 155 | 308 | 281 185 51.89% | 429 311 37.89% | 710 592 19.91% | 216 220 -1.8% | 194 214 -9.34% | 410 430 -4.64% | 265 | 144 189 -23.86% | 157 | 298 | 173 | 145 | 370 | 226 | 267 | 493 |
|
EPS JPY | Released Forecast Spread | 6,64 | 14,5 | 8,36 | 16,5 | 15,0 | 11,6 | 10,4 | 21,9 | 14,1 | 7,27 | ||||||||||
| Announcement Date | 15/06/20 | 14/06/21 | 16/03/22 | 13/06/22 | 13/09/22 | 14/12/22 | 14/12/22 | 14/03/23 | 14/06/23 | 14/06/23 | 13/09/23 | 11/03/24 | - | - | - | - | - | - | - | - |
| 2024-04-26 | DIAN DIAGNOSTICS GROUP CO.,LTD.: Q1 2024 Earnings Release |
| 2024-04-26 | SHANGHAI LABWAY CLINICAL LABORATORY CO., LTD: Q1 2024 Earnings Release |
| 2024-04-26 | SHANGHAI LABWAY CLINICAL LABORATORY CO., LTD: Q4 2023 Earnings Release |
| 2024-04-28 | SMO CLINPLUS CO.,LTD.: Q4 2023 Earnings Release |
| 2024-04-29 | NEOGENOMICS, INC.: Q1 2024 Earnings Release |
| 2024-05-03 07:00 am | FULGENT GENETICS, INC.: Q1 2024 Earnings Release |
| 2024-05-05 | OPKO HEALTH, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-07 | RADNET, INC.: Q1 2024 Earnings Release |
| 2024-05-07 | SYNLAB AG: Q1 2024 Earnings Release |
| 2024-05-08 | FLEURY S.A.: Q1 2024 Earnings Release |
Past sector events for CellSource Co., Ltd.
| Today | GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.: Q1 2024 Earnings Release |
| Today | GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-24 | BERRY GENOMICS CO.,LTD: Q4 2023 Earnings Release |
| 2024-04-23 | NOVOGENE CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-19 | DIAN DIAGNOSTICS GROUP CO.,LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | NOVOGENE CO., LTD.: Q4 2023 Earnings Release |
| 2024-03-27 | ADICON HOLDINGS LIMITED: Q4 2023 Earnings Release |
| 2024-03-25 02:00 am | SYNLAB AG: Q4 2023 Earnings Release |
| 2024-03-06 | FLEURY S.A.: Q4 2023 Earnings Release |
| 2024-02-29 04:10 pm | RADNET, INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4880 Stock
- Calendar CellSource Co., Ltd.
